In agreement with this, RARB was found to suppresses MAPK kinase kinase 2 to inactivate the MAPK signaling, and the RARB downregulation by miRNA-106a led to MAPK activation and increased the apoptosis of thyroid cancer cells [55]. This evidence concerns the gene RARB and thyroid gland carcinoma.